These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 21965160)

  • 21. Improving performance of mammalian cells in fed-batch processes through "bioreactor evolution".
    Prentice HL; Ehrenfels BN; Sisk WP
    Biotechnol Prog; 2007; 23(2):458-64. PubMed ID: 17311405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of a novel cell line, CHO-MK, derived from Chinese hamster ovary tissues for biologics manufacturing.
    Masuda K; Kubota M; Nakazawa Y; Iwama C; Watanabe K; Ishikawa N; Tanabe Y; Kono S; Tanemura H; Takahashi S; Makino T; Okumura T; Horiuchi T; Nonaka K; Murakami S; Kamihira M; Omasa T
    J Biosci Bioeng; 2024 Jun; 137(6):471-479. PubMed ID: 38472071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in efficiency of media utilization for recombinant protein production in Chinese hamster ovary culture through dilution.
    Thombre S; Gadgil M
    Biotechnol Appl Biochem; 2011; 58(1):25-31. PubMed ID: 21446956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development and application of perfusion culture producing seed cells in WAVE bioreactor].
    Yang J; Sui L
    Sheng Wu Gong Cheng Xue Bao; 2012 Mar; 28(3):358-67. PubMed ID: 22712394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
    Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
    Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium.
    Link T; Bäckström M; Graham R; Essers R; Zörner K; Gätgens J; Burchell J; Taylor-Papadimitriou J; Hansson GC; Noll T
    J Biotechnol; 2004 May; 110(1):51-62. PubMed ID: 15099905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cell-detaching reactor for inoculation of anchorage-dependent CHO and Vero cells between stepwise-expanded bioreactors.
    Sun X; Zhang Y
    Biotechnol Lett; 2007 May; 29(5):697-701. PubMed ID: 17216536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-end pH-controlled delivery of glucose effectively suppresses lactate accumulation in CHO fed-batch cultures.
    Gagnon M; Hiller G; Luan YT; Kittredge A; DeFelice J; Drapeau D
    Biotechnol Bioeng; 2011 Jun; 108(6):1328-37. PubMed ID: 21328318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
    Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.
    Legmann R; Schreyer HB; Combs RG; McCormick EL; Russo AP; Rodgers ST
    Biotechnol Bioeng; 2009 Dec; 104(6):1107-20. PubMed ID: 19623562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
    Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
    Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feed development for fed-batch CHO production process by semisteady state analysis.
    Khattak SF; Xing Z; Kenty B; Koyrakh I; Li ZJ
    Biotechnol Prog; 2010; 26(3):797-804. PubMed ID: 20014108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fed-batch operation of an industrial cell culture process in shaken microwells.
    Silk NJ; Denby S; Lewis G; Kuiper M; Hatton D; Field R; Baganz F; Lye GJ
    Biotechnol Lett; 2010 Jan; 32(1):73-8. PubMed ID: 19760119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors.
    Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
    Biotechnol Bioeng; 2006 Aug; 94(6):1033-44. PubMed ID: 16736530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enhancement of recombinant protein production by polymer nanospheres in cell suspension culture.
    Ryu JH; Kim MS; Lee GM; Choi CY; Kim BS
    Biomaterials; 2005 May; 26(14):2173-81. PubMed ID: 15576193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells.
    Chiang GG; Sisk WP
    Biotechnol Bioeng; 2005 Sep; 91(7):779-92. PubMed ID: 15986489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
    Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
    Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple and efficient control of CHO cell cultures.
    Aehle M; Schaepe S; Kuprijanov A; Simutis R; Lübbert A
    J Biotechnol; 2011 Apr; 153(1-2):56-61. PubMed ID: 21419815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a fed-batch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells.
    Kuwae S; Ohda T; Tamashima H; Miki H; Kobayashi K
    J Biosci Bioeng; 2005 Nov; 100(5):502-10. PubMed ID: 16384788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-temperature pausing of cultivated mammalian cells.
    Hunt L; Hacker DL; Grosjean F; De Jesus M; Uebersax L; Jordan M; Wurm FM
    Biotechnol Bioeng; 2005 Jan; 89(2):157-63. PubMed ID: 15584025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.